Terms: = Uterine cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Prognosis
100 results:
1. Genomic profile of Chinese patients with endometrial carcinoma.
Li J; Li X; Quan C; Li X; Wan C; Wu X
BMC Cancer; 2023 Sep; 23(1):888. PubMed ID: 37730563
[TBL] [Abstract] [Full Text] [Related]
2. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
J Gynecol Oncol; 2023 Sep; 34(5):e85. PubMed ID: 37593813
[TBL] [Abstract] [Full Text] [Related]
3. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
[TBL] [Abstract] [Full Text] [Related]
4. Comparison between radical surgery and chemoradiotherapy in patients with cervical esophageal cancer: a propensity score matched analysis.
Qi K; Lin G; Liu H; Zhang X; Chen Z; Li J
BMC Surg; 2023 May; 23(1):119. PubMed ID: 37170089
[TBL] [Abstract] [Full Text] [Related]
5. Gynecological cancer prognosis using machine learning techniques: A systematic review of the last three decades (1990-2022).
Sheehy J; Rutledge H; Acharya UR; Loh HW; Gururajan R; Tao X; Zhou X; Li Y; Gurney T; Kondalsamy-Chennakesavan S
Artif Intell Med; 2023 May; 139():102536. PubMed ID: 37100507
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological features and immunophenotype of Silva pattern system in endocervical adenocarcinoma.
Zeng C; Wu JK; Lu X
Int J Exp Pathol; 2023 Jun; 104(3):140-150. PubMed ID: 36928883
[TBL] [Abstract] [Full Text] [Related]
7. Clinical characteristics and outcomes of cervical lymph node metastasis from unknown primary sites: a single institution's 14-year experience.
Zhou M; Wu Y; Wu Y; Li H; Ye B; Yue K; Jing C; Duan Y; Wang X
Eur J Med Res; 2023 Jan; 28(1):5. PubMed ID: 36597158
[TBL] [Abstract] [Full Text] [Related]
8. Villoglandular Pattern in HPV-associated Endocervical Adenocarcinoma is Associated With Excellent prognosis: A Reappraisal of 31 Cases Using IECC and Silva Pattern Classification.
Stolnicu S; Brito MJ; Karpathiou G; Hoang L; Felix A; Mateoiu C; Fanni D; Reques A; Garcia A; Hardisson D; Talu CK; Furtado A; Abu-Rustum N; Soslow RA; Park KJ
Int J Gynecol Pathol; 2023 May; 42(3):270-277. PubMed ID: 36508680
[TBL] [Abstract] [Full Text] [Related]
9. The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiation.
Sun Y; Li G; Hai P; Cao Y; Han P; Liu Y; Wen J; Wang Y; Cheng X; Ren F
World J Surg Oncol; 2022 Dec; 20(1):389. PubMed ID: 36476481
[TBL] [Abstract] [Full Text] [Related]
10. Recurrence and Survival Rates of Patients Who Undergo Minimally Invasive Surgery for Endometrial Carcinoma with Different Prognostic Risk Groups.
Liu B; Lin J; Liu W; Chen W; Lin W; Chen W
J Invest Surg; 2023 Dec; 36(1):1-10. PubMed ID: 36341742
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic factors for squamous cervical carcinoma identified by competing-risks analysis: A study based on the SEER database.
Hu C; Cao J; Zeng L; Luo Y; Fan H
Medicine (Baltimore); 2022 Sep; 101(39):e30901. PubMed ID: 36181049
[TBL] [Abstract] [Full Text] [Related]
12. Microsatellite instability as a marker of prognosis: a systematic review and meta-analysis of endometrioid endometrial cancer survival data.
Xiao JP; Wang JS; Zhao YY; Du J; Wang YZ
Arch Gynecol Obstet; 2023 Feb; 307(2):573-582. PubMed ID: 35665848
[TBL] [Abstract] [Full Text] [Related]
13. Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients.
Omenai SA; Ajani MA; Okolo CA
PLoS One; 2022; 17(2):e0263615. PubMed ID: 35139126
[TBL] [Abstract] [Full Text] [Related]
14. Targeting cancer metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with metformin for Endometrial cancer Patients with Diabetes.
Yang X; Cheng Y; Zhou J; Zhang L; Li X; Wang Z; Yin S; Zhai L; Huang T; Wu X; Shen B; Dong Y; Zhao L; Chi Y; Jia Y; Wang J; He Y; Dong X; Xiao H; Wang J
Adv Sci (Weinh); 2022 Mar; 9(8):e2104472. PubMed ID: 35064767
[TBL] [Abstract] [Full Text] [Related]
15. Stratified follow-up for endometrial cancer: a move to more personalized cancer care.
Sarwar A; Van Griethuysen J; Waterhouse J; Dehbi HM; Eminowicz G; McCormack M
Int J Gynecol Cancer; 2021 Dec; 31(12):1564-1571. PubMed ID: 34795021
[TBL] [Abstract] [Full Text] [Related]
16. Pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis.
Zhou P; Zhang Y; Luo S; Zhang S
Radiother Oncol; 2021 Dec; 165():103-118. PubMed ID: 34718055
[TBL] [Abstract] [Full Text] [Related]
17. CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
Coquan E; Brachet PE; Licaj I; Leconte A; Castera M; Lequesne J; Meriaux E; Bonnet I; Lelaidier A; Clarisse B; Joly F
BMC Cancer; 2021 Sep; 21(1):1054. PubMed ID: 34563169
[TBL] [Abstract] [Full Text] [Related]
18.
Kaneko E; Sato N; Sugawara T; Noto A; Takahashi K; Makino K; Terada Y
J Gynecol Oncol; 2021 Nov; 32(6):e79. PubMed ID: 34431253
[TBL] [Abstract] [Full Text] [Related]
19. Application of Da Vinci robotic surgery system in cervical cancer: A single institution experience of 557 cases.
Li J; Gong X; Li P; Xiao L; Chang X; Ouyang X; Tang J
Asian J Surg; 2022 Feb; 45(2):707-711. PubMed ID: 34373166
[TBL] [Abstract] [Full Text] [Related]
20. Primary Mediastinal Nonseminomas: A Population-Based Surveillance, Epidemiology, and End Results Analysis.
Yang X; Zhao K; Mei J; Wei S; Xia L; Pu Y; Liu L
J Surg Res; 2021 Nov; 267():25-36. PubMed ID: 34126390
[TBL] [Abstract] [Full Text] [Related]
[Next]
